Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously

Clinical and Experimental Immunology

Volumn 162, Issue 2, 2010, Pages 224-236

  Zakka, L R ^a   Keskin, D B ^b   Reche, P ^c   Ahmed, A R ^a  

^a NEW ENGLAND BAPTIST HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Autoantibodies; Bullous pemphigoid; Epitope spreading; Mhcclass II genes; Mucous membrane pemphigoid; Pemphigus vulgaris

Indexed keywords

AUTOANTIBODY; EPITOPE; HLA DQB1 ANTIGEN;

ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; FEMALE; GENE; HAPLOTYPE; HISTOLOGY; HUMAN; IMMUNOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS 2 GENE; MALE; MUCOSA; MUCOUS MEMBRANE PEMPHIGOID; PEMPHIGOID; PEMPHIGUS VULGARIS; PHENOTYPE; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTIBODY FORMATION; ANTIGENS, SURFACE; AUTOANTIBODIES; AUTOANTIGENS; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; DESMOGLEIN 1; DESMOGLEIN 3; EPITOPES, T-LYMPHOCYTE; FEMALE; GENES, MHC CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INTEGRIN ALPHA6; INTEGRIN BETA4; KERATINOCYTES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGOID, BULLOUS; PEMPHIGUS; SOFTWARE; YOUNG ADULT;

EID: 78649269242     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04239.x     Document Type: Article

References (141)

1. Ahmed AR, Graham J, Jordon RE, Provost TT. Pemphigus: current concepts. Ann Intern Med 1980; 92:396-405.
2. Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet 1999; 354:667-72.
3. Lever WF. Pemphigus and pemphigoid. A review of the advances made since 1964. J Am Acad Dermatol 1979; 1:2-31.
4. Sami N, Bhol KC, Beutner EH et al. Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: molecular characterization of both autoantibodies. Clin Immunol 2001; 100:219-27.
5. Beutner EH, Jordon RE, Chorzelski TP. The immunopathology of pemphigus and bullous pemphigoid. 1968. J Invest Dermatol 1989; 92:166S; discussion 7S-8S.
6. Fleming TE, Korman NJ. Cicatricial pemphigoid. J Am Acad Dermatol 2000; 43:571-91; quiz 91-4.
7. Scully C. A review of common mucocutaneous disorders affecting the mouth and lips. Ann Acad Med Singapore 1999; 28:704-7.
8. Sami N, Ahmed AR. Dual diagnosis of pemphigus and pemphigoid. Retrospective review of thirty cases in the literature. Dermatology 2001; 202:293-301.
9. Grando SA. Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology 2000; 201:290-5.
10. Weissman V, Feuerman EJ, Joshua H, Hazaz B. The correlation between the antibody titers in sera of patients with pemphigus vulgaris and their clinical state. J Invest Dermatol 1978; 71:107-9.
11. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999; 40:167-70.
12. Ishii K, Amagai M, Hall RP et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997; 159:2010-17.
13. McCuin JB, Hanlon T, Mutasim DF. Autoimmune bullous diseases: diagnosis and management. Dermatol Nurs 2006; 18:20-5.
14. Scott JE, Ahmed AR. The blistering diseases. Med Clin North Am 1998; 82:1239-83.
15. Wojnarowska F, Venning VA, Burge SM. Immunobullous diseases, 7th edn. Malden, MA: Blackwell Science Ltd, 2008.
16. Yunis JJ, Mobini N, Yunis EJ et al. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci USA 1994; 91:7747-51.
17. Bhol KC, Goss L, Kumari S, Colon JE, Ahmed AR. Autoantibodies to human alpha6 integrin in patients with oral pemphigoid. J Dent Res 2001; 80:1711-15.
18. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster CS, Ahmed AR. Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci USA 1996; 93:14714-19.
19. Bhol KC, Dans MJ, Simmons RK, Foster CS, Giancotti FG, Ahmed AR. The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4. J Immunol 2000; 165:2824-9.
20. Kumari S, Bhol KC, Simmons RK et al. Identification of ocular cicatricial pemphigoid antibody binding site(s) in human beta4 integrin. Invest Ophthalmol Vis Sci 2001; 42:379-85.
21. Rose C, Schmidt E, Kerstan A et al. Histopathology of anti-laminin mucous membrane pemphigoid. J Am Acad Dermatol 2009; 61:433-40.
22. Fukushima S, Egawa K, Nishi H et al. Two cases of anti-epiligrin cicatricial pemphigoid with and without associated malignancy. Acta Derm Venereol 2008; 88:484-7.
23. Sadler E, Lazarova Z, Sarasombath P, Yancey KB. A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer. J Dermatol Sci 2007; 47:1-7.
24. Ahmed AR, Workman S. Anti-intercellular substance antibodies. Presence in serum samples of 14 patients without pemphigus. Arch Dermatol 1983; 119:17-21.
25. Cram DL, Griffith MR, Fukuyama K. Pemphigus-like antibodies in cicatricial pemphigoid. Arch Dermatol 1974; 109:235-8.
26. Kumar V, Yarbrough C, Beutner EH. Complement-fixing intercellular antibodies in a case of cicatricial pemphigoid. Arch Dermatol 1980; 116:812-14.
27. Roenigk HH Jr, Deodhar S. Pemphigus treatment with azathioprine. Clinical and immunologic correlation. Arch Dermatol 1973; 107:353-7.
28. Buhac J, Bhol K, Padilla T Jr, Foster CS, Ahmed AR. Coexistence of pemphigus vulgaris and ocular cicatricial pemphigoid. J Am Acad Dermatol 1996; 34:884-6.
29. Ead RD. Pemphigus-like antibodies: a report of two cases. Br J Dermatol 1979; 100:723-5.
30. Smolle J, Kerl H. Pitfalls in the diagnosis of pemphigus vulgaris (early pemphigus vulgaris with features of bullous pemphigoid). Am J Dermatopathol 1984; 6:429-35.
31. Leibovici V, Ron N, Goldenhersh M, Holubar K. Coexistence of pemphigus and bullous pemphigoid. Int J Dermatol 1989; 28:259-60.
32. Matsubara K, Kanauchi H, Tanaka T, Imamura S. Coexistence of pemphigus and bullous pemphigoid. J Dermatol 1995; 22:68-71.
33. Takahashi H, Wada T, Matsuo S, Iwatsuki K, Iizuka H. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen. J Dermatol 1995; 22:576-81.
34. Bernard P, Catanzano G, Vignaud St Florent JD, Fayol J, Bonnetblanc JM [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases]. Ann Dermatol Venereol 1986; 113:671-6.
35. Chorzelski TP, Maciejowski E, Jablonska S et al. Coexistence of pemphigus and bullous pemphigoid. Arch Dermatol 1974; 109:849-53.
36. Kore-eda S, Horiguchi Y, Ohtoshi E et al. A case of autoimmune bullous dermatosis with features of pemphigus vulgaris and bullous pemphigoid. Am J Dermatopathol 1995; 17:511-16.
37. Ninomiya J, Nakabayashi A, Sei Y, Takiuchi I. Bullous pemphigoid complicated with pemphigus vulgaris? Dermatology 1994; 189 (Suppl. 1):117-19.
38. Velthuis PJ, Hendrikse JC, Nefkens JJ. Combined features of pemphigus and pemphigoid induced by penicillamine. Br J Dermatol 1985; 112:615-19.
39. Dobmeier LJ, Sams WMJr, Beutner EH. Intercellular antibodies in a patient without clinical pemphigus. Ann NY Acad Sci 1971; 177:218-23.
40. Batista FD, Harwood NE. The who, how and where of antigen presentation to B cells. Nat Rev Immunol 2009; 9:15-27.
41. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001; 1:147-53.
42. Barnadas MA, Rubiales MV, Gonzalez MJ et al. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis. Int J Dermatol 2008; 47:1245-9.
43. Kobayashi M, Amagai M, Kuroda-Kinoshita K et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002; 30:224-32.
44. Amagai M, Komai A, Hashimoto T et al. Usefulness of enzymelinked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999; 140:351-7.
45. Bunce M, Welsh K. PCR-SSP typing of HLA class I and class II alleles, 4th edn. Mt. Laurel, NJ: ASHI Publications, 2000.
46. Lafuente EM, Reche PA. Prediction of MHC-peptide binding: a systematic and comprehensive overview. Curr Pharm Des 2009; 15:3209-20.
47. Reche PA, Glutting JP, Reinherz EL. Prediction of MHC class I binding peptides using profile motifs. Hum Immunol 2002; 63:701-9.
48. Reche PA, Glutting JP, Zhang H, Reinherz EL. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 2004; 56:405-19.
49. Reche PA, Keskin DB, Hussey RE, Ancuta P, Gabuzda D, Reinherz EL. Elicitation from virus-naive individuals of cytotoxic T lymphocytes directed against conserved HIV-1 epitopes. Med Immunol 2006; 5:1.
50. Ahmed AR, Park MS, Tiwari JL, Terasaki PI. Association of DR4 with pemphigus. Exp Clin Immunogenet 1987; 4:8-16.
51. Lombardi ML, Mercuro O, Ruocco V et al. Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients. J Invest Dermatol 1999; 113:107-10.
52. Tong JC, Bramson J, Kanduc D, Chow S, Sinha AA, Ranganathan S. Modeling the bound conformation of pemphigus vulgarisassociated peptides to MHC class II DR and DQ alleles. Immunome Res 2006; 2:1.
53. Delgado JC, Hameed A, Yunis JJ et al. Pemphigus vulgaris autoantibody response is linked toHLA-DQB1*0503 in Pakistani patients. Hum Immunol 1997; 57:110-19.
54. Loiseau P, Lecleach L, Prost C et al. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus. J Autoimmun 2000; 15:67-73.
55. Miyagawa S, Higashimine I, Iida T, Yamashina Y, Fukumoto T, Shirai T. HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese. J Invest Dermatol 1997; 109:615-18.
56. Lee E, Lendas KA, Chow S et al. Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris. Hum Immunol 2006; 67:125-39.
57. Tron F, Gilbert D, Mouquet H et al. Genetic factors in pemphigus. J Autoimmun 2005; 24:319-28.
58. Gazit E, Loewenthal R. The immunogenetics of pemphigus vulgaris. Autoimmun Rev 2005; 4:16-20.
59. Ahmed AR, Wagner R, Khatri K et al. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1991; 88:5056-60.
60. Sinha AA, Brautbar C, Szafer F et al. A newly characterized HLA DQ beta allele associated with pemphigus vulgaris. Science 1988; 239:1026-9.
61. Loewenthal R, Slomov Y, Gonzalez-Escribano MF et al. Common ancestral origin of pemphigus vulgaris in Jews and Spaniards: a study using microsatellite markers. Tissue Antigens 2004; 63:326-34.
62. Glorio R, Rodriguez Costa G, Haas R, Gruber M, Fainboim L, Woscoff A. HLA haplotypes and class II molecular alleles in Argentinian patients with pemphigus vulgaris. J Cutan Med Surg 2002; 6:422-6.
63. Brick C, Belgnaoui FZ, Atouf O et al. Pemphigus and HLA in Morocco. Transfus Clin Biol 2007; 14:402-6.
64. Delgado JC, Yunis DE, Bozon MV et al. MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India. Tissue Antigens 1996; 48:668-72.
65. Carcassi C, Cottoni F, Floris L et al. HLA haplotypes and class II molecular alleles in Sardinian and Italian patients with pemphigus vulgaris. Tissue Antigens 1996; 48:662-7.
66. Gonzalez-Escribano MF, Jimenez G, Walter K et al. Distribution of HLA class II alleles among Spanish patients with pemphigus vulgaris. Tissue Antigens 1998; 52:275-8.
67. Delgado JC, Turbay D, Yunis EJ et al. A common major histocompatibility complex class II allele HLA-DQB1*0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci USA 1996; 93:8569-71.
68. Chan LS, Hammerberg C, Cooper KD. Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid. J Invest Dermatol 1997; 108:129-32.
69. Setterfield J, Theron J, Vaughan RWet al. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol 2001; 145:406-14.
70. Drouet M, Delpuget-Bertin N, Vaillant L et al. HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians. Eur J Dermatol 1998; 8: 330-3.
71. Haider N, Neuman R, Foster CS, Ahmed AR. Report on the sequence of DQB1*0301 gene in ocular cicatricial pemphigoid patients. Curr Eye Res 1992; 11:1233-8.
72. Carrozzo M, Fasano ME, Broccoletti R et al. HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity. Br J Dermatol 2001; 145:805-8.
73. Oyama N, Setterfield JF, Powell AM et al. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Br J Dermatol 2006; 154:90-8.
74. Ahmed AR, Foster S, Zaltas M et al. Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid. Proc Natl Acad Sci USA 1991; 88:11579-82.
75. Hertl M, Karr RW, Amagai M, Katz SI. Heterogeneous MHC II restriction pattern of autoreactive desmoglein 3 specific T cell responses in pemphigus vulgaris patients and normals. J Invest Dermatol 1998; 110:388-92.
76. Miyagawa S, Amagai M, Niizeki H et al. HLA-DRB1 polymorphisms and autoimmune responses to desmogleins in Japanese patients with pemphigus. Tissue Antigens 1999; 54:333-40.
77. Saenz-Cantele AM, Fernandez-Mestre M, Montagnani S, Calebotta A, Balbas O, Layrisse Z. HLA-DRB1*0402 haplotypes without DQB1*0302 in Venezuelan patients with pemphigus vulgaris. Tissue Antigens 2007; 69:318-25.
78. Huang CY, Chen TC. Bullous pemphigoid associated with systemic lupus erythematosus: the discrimination of antibasement membrane zone antibody. Int J Dermatol 1997; 36:40-2.
79. Stoll DM, King LE Jr. Association of bullous pemphigoid with systemic lupus erythematosus. Arch Dermatol 1984; 120:362-6.
80. Clayton CA, Burnham TK. Systemic lupus erythematosus and coexisting bullous pemphigoid: immunofluorescent investigations. J Am Acad Dermatol 1982; 7:236-45.
81. Sant SM, O'Loughlin S, Murphy GM. Bullous pemphigoid and rheumatoid arthritis: is there disease association? Ir JMed Sci 1997; 166:106-7.
82. Hsu VM, Krey PR, Schwartz RA. Bullous pemphigoid and rheumatoid arthritis. Cutis 1989; 43:30-2.
83. Giannini JM, Callen JP, Gruber GG. Bullous pemphigoid and rheumatoid arthritis. J Am Acad Dermatol 1981; 4:695-7.
84. Walker MJ. Bullous pemphigoid and rheumatoid arthritis with herpes simplex in the vesicular fluid. Cutis 1977; 19:93-4.
85. Yamamoti T, Yokoyama A, Mamada A, Miyazaki Y, Nishioka K. Familial occurrence of coexistence of bullous pemphigoid and Sjogren's syndrome. Int J Dermatol 1998; 37:475-6.
86. James WD. Bullous pemphigoid, myasthenia gravis, and thymoma. Arch Dermatol 1984; 120:397.
87. Kirtschig G, Walkden VM, Venning VA, Wojnarowska F. Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature. Clin Exp Dermatol 1995; 20:449-53.
88. Masouye I, Schmied E, Didierjean L, Abba Z, Saurat JH. Bullous pemphigoid and multiple sclerosis: more than a coincidence? Report of three cases. J Am Acad Dermatol 1989; 21:63-8.
89. Nielsen NM, Frisch M, Rostgaard K et al. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark. Mult Scler 2008; 14: 823-9.
90. Malik M, Gurcan HM, Ahmed AR. Coexistence of mucous membrane pemphigoid and connective-tissue disease. Clin Exp Dermatol 2010; 35:156-9.
91. Redman RS, Thorne EG. Cicatricial pemphigoid in a patient with systemic lupus erythematosus. Arch Dermatol 1981; 117:109-10.
92. Spigel GT, Winkelmann RK. Cicatricial pemphigoid and rheumatoid arthritis. Arch Dermatol 1978; 114:415-17.
93. Olsen KE, Holland EJ. The association between ocular cicatricial pemphigoid and rheumatoid arthritis. Cornea 1998; 17:504-7.
94. Peyri J, Servitje O, Ribera M, Henkes J, Ferrandiz C. Cicatricial pemphigoid in a patient with rheumatoid arthritis treated with d-penicillamine. J Am Acad Dermatol 1986; 14:681.
95. Spigel GT. Association of cicatricial pemphigoid and rheumatoid arthritis. Arch Dermatol 1979; 115:108-9.
96. Malik M, Ahmed AR. Concurrence of systemic lupus erythematosus and pemphigus: coincidence or correlation? Dermatology 2007; 214:231-9.
97. Chan HL. Pemphigus vulgaris associated with systemic lupus erythematosus. Int J Dermatol 1999; 38:948.
98. Kuchabal DS, Kuchabal SD, Pandit AM, Nashi HK. Pemphigus vulgaris associated with systemic lupus erythematosus. Int J Dermatol 1998; 37:636-8.
99. Fong PH, Chan HL. Systemic lupus erythematosus with pemphigus vulgaris. Arch Dermatol 1985; 121:26-7.
100. Russell JG. Pemphigus, Sjogren's syndrome and mucosal pigmentation. Acta Stomatol Int 1987; 8:25-9.
101. Meiner Z, Zlotogorski A, Brautbar C. Pemphigus associated with multiple sclerosis. Clin Exp Dermatol 1992; 17:217.
102. Friedel J, Jeandel C, Abensour M, Heid E. Multiple sclerosis and autoimmune skin bullae: a case of pemphigus vulgaris. Dermatologica 1987; 175:159-60.
103. Hamlet KR, Stevens SR, Gushurst C, Karabin G, Cooper KD. Juvenile pemphigus vulgaris associated with Graves' disease. J AmAcad Dermatol 1995; 33:132-4.
104. Shabbir SG, Hassan M, Kazmi SA, Suhail S. Myasthenia gravis and pemphigus vulgaris. J Pak Med Assoc 1984; 34:349-51.
105. Noguchi S, Nishitani H. [Case of myasthenia gravis associated with pemphigus vulgaris following thymectomy. Immunological studies and a review of the literature]. Rinsho Shinkeigaku 1976; 16:625-32.
106. Shapiro M, Jimenez S, Werth VP. Pemphigus vulgaris induced by d-penicillamine therapy in a patient with systemic sclerosis. J Am Acad Dermatol 2000; 42:297-9.
107. Maize JC, Dobson RL, Provost TT. Pemphigus and myasthenia gravis. Arch Dermatol 1975; 111:1334-9.
108. Wolf R, Feuerman EJ. Pemphigus in association with autoimmune thyroid disease. Cutis 1981; 27:423-4, 31.
109. Grandhe NP, Dogra S, Kanwar AJ. Multiple autoimmune syndrome in a patient with pemphigus vulgaris. Acta Derm Venereol 2005; 85:91-2.
110. Nanda A, Kapoor MM, Dvorak R, Al-Sabah H, Alsaleh QA. Coexistence of pemphigus vulgaris with systemic lupus erythematosus. Int J Dermatol 2004; 43:393-4.
111. Somorin AO, Agbakwu SN, Nwaefuna A. Systemic lupus erythematosus and pemphigus vulgaris preceded by depressive psychosis. Cent Afr J Med 1981; 27:12-14.
112. Hidalgo-Tenorio C, Sabio-Sanchez JM, Tercedor-Sanchez J, Leon-Ruiz L, Perez-Alvarez F, Jimenez-Alonso J. Pemphigus vulgaris and systemic lupus erythematosus in a 46-y-old man. Lupus 2001; 10:824-6.
113. Malik M, Ahmed AR. Dual diagnosis of pemphigus vulgaris and connective tissue disease. J Am Acad Dermatol 2006; 55:699-704.
114. Somers EC, Thomas SL, Smeeth L, Hall AJ. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 2006; 17:202-17.
115. Panczel P, Falus A, Meretey K et al. [Association between cumulative familial incidence of type I diabetes and rheumatoid arthritis]. Orv Hetil 1985; 126:1281-4, 7-9.
116. Thomas DJ, Young A, Gorsuch AN, Bottazzo GF, Cudworth AG. Evidence for an association between rheumatoid arthritis and autoimmune endocrine disease.Ann Rheum Dis 1983; 42:297-300.
117. Becker KL, Titus JL, Woolner LB, Ferguson RH. Thyroiditis and rheumatoid arthritis. Proc Staff Meet Mayo Clin 1963; 38:125-9.
118. Shiroky JB, Cohen M, Ballachey ML, Neville C. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis 1993; 52:454-6.
119. Pongratz R, Buchinger W, Semlitsch G, Meister E, Nadler K, Rainer F. [Increased occurrence of autoimmune thyroiditis in patients with chronic rheumatoid arthritis]. Acta Med Austriaca 2000; 27:58-60.
120. Alpigiani MG, Cerboni M, Bertini I et al. Endocrine autoimmunity in young patients with juvenile chronic arthritis. Clin Exp Rheumatol 2002; 20:565-8.
121. Wynn DR, Rodriguez M, O'Fallon WM, Kurland LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990; 40:780-6.
122. Baker HW, Balla JI, Burger HG, Ebeling P, Mackay IR. Multiple sclerosis and autoimmune diseases. Aust NZ JMed 1972; 2:256-60.
123. Midgard R, Gronning M, Riise T, Kvale G, Nyland H. Multiple sclerosis and chronic inflammatory diseases. A case-control study. Acta Neurol Scand 1996; 93:322-8.
124. De Keyser J. Autoimmunity in multiple sclerosis. Neurology 1988; 38:371-4.
125. Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DA. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 2000; 123:1102-11.
126. Barcellos LF, Kamdar BB, Ramsay PP et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 2006; 5:924-31.
127. Heinzlef O, Alamowitch S, Sazdovitch V et al. Autoimmune diseases in families of French patients with multiple sclerosis. Acta Neurol Scand 2000; 101:36-40.
128. Laroni A, Calabrese M, Perini P et al. Multiple sclerosis and autoimmune diseases: epidemiology and HLA-DR association in North-east Italy. J Neurol 2006; 253:636-9.
129. Neuhausen SL, Steele L, Ryan S et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their firstdegree relatives. J Autoimmun 2008; 31:160-5.
130. Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997; 136:315-18.
131. Asakawa H, Kashihara T, Fukuda H, Yamamoto M. A patient with thymoma and four different organ-specific autoimmune diseases. Neth J Med 2002; 60:292-5.
132. McCluskey J, Farris AD, Keech CL et al. Determinant spreading: lessons from animal models and human disease. Immunol Rev 1998; 164:209-29.
133. Mitchison NA. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur J Immunol 1971; 1:18-27.
134. Lake P, Mitchison NA. Regulatory mechanisms in the immune response to cell-surface antigens. Cold Spring Harb Symp Quant Biol 1977; 41 (Pt 2):589-95.
135. Mamula MJ. Lupus autoimmunity: from peptides to particles. Immunol Rev 1995; 144:301-14.
136. Mamula MJ, Janeway CA Jr. Do B cells drive the diversification of immune responses? Immunol Today 1993; 14:151-2; discussion 3-4.
137. Roth R, Gee RJ, Mamula MJ. B lymphocytes as autoantigenpresenting cells in the amplification of autoimmunity. Ann NY Acad Sci 1997; 815:88-104.
138. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358:155-7.
139. Chan LS, Vanderlugt CJ, Hashimoto T et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998; 110:103-9.
140. Chan LS, Soong HK, Foster CS, Hammerberg C, Cooper KD. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome. JAMA 1991; 266:1543-6.
141. Paisansinsup T, Deshmukh US, Chowdhary VR, Luthra HS, Fu SM, David CS. HLA class II influences the immune response and antibody diversification to Ro60/Sjogren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol 2002; 168:5876-84.